These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27266439)

  • 1. Greater potential cost savings with biosimilar use.
    Yu B
    Am J Manag Care; 2016 May; 22(5):378. PubMed ID: 27266439
    [No Abstract]   [Full Text] [Related]  

  • 2. Friction in the Path to Use of Biosimilar Drugs.
    Frank RG
    N Engl J Med; 2018 Mar; 378(9):791-793. PubMed ID: 29490182
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA.
    Bennett CL; Sartor OA; Armitage JO; Kantarjian H
    Lancet Oncol; 2017 Jan; 18(1):22-23. PubMed ID: 28049571
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescription drug prices in the US.
    Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and Medical Devices: Cost Savings.
    Steiner DJ;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-31. PubMed ID: 27116794
    [No Abstract]   [Full Text] [Related]  

  • 6. Biosimilar drugs: Measures to promote their use.
    Guiu Segura JM; Gilabert Perramon A
    Med Clin (Barc); 2020 Feb; 154(4):148. PubMed ID: 30981435
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of specialty pharmaceuticals as drivers of health care costs.
    Hirsch BR; Balu S; Schulman KA
    Health Aff (Millwood); 2014 Oct; 33(10):1714-20. PubMed ID: 25288414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Save green, go generic: be prepared to answer the $4 question.
    Hansen D
    S D Med; 2009 Nov; 62(11):436-7. PubMed ID: 20128174
    [No Abstract]   [Full Text] [Related]  

  • 9. Fate of cost-saving biosimilar drugs may hinge on naming policy.
    Johnson SR
    Mod Healthc; 2016 Aug; 45(27):7, 9. PubMed ID: 30387953
    [No Abstract]   [Full Text] [Related]  

  • 10. The rise of biosimilars in cancer care.
    Roe H
    Br J Nurs; 2015 Feb 26-Mar 11; 24(4):S28-9. PubMed ID: 25723369
    [No Abstract]   [Full Text] [Related]  

  • 11. Biosimilars for insulin: a cost-saving alternative?
    McCall C
    Lancet; 2018 Aug; 392(10146):463-464. PubMed ID: 30129449
    [No Abstract]   [Full Text] [Related]  

  • 12. Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia.
    Cesarec A; Likić R
    Appl Health Econ Health Policy; 2017 Apr; 15(2):277-286. PubMed ID: 27730538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosimilars for Management of Crohn Disease.
    Nielsen OH; Ainsworth MA
    Ann Intern Med; 2019 Jan; 170(2):129-130. PubMed ID: 30535358
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficiency: Prescription for challenging times.
    Forde C
    Health Serv J; 2012 Jan; 122(6291):30-1. PubMed ID: 22468432
    [No Abstract]   [Full Text] [Related]  

  • 15. Save money on your prescription medications. Comparison shopping, assistance programs, and prescription price finders can help.
    Harv Health Lett; 2014 Feb; 39(4):5. PubMed ID: 24683616
    [No Abstract]   [Full Text] [Related]  

  • 16. Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018.
    Hernandez I; Good CB; Shrank WH; Gellad WF
    JAMA; 2019 Apr; 321(16):1627-1629. PubMed ID: 30907933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologicals and how they revolutionized rheumatology.
    Grisar J
    Wien Med Wochenschr; 2015 Jan; 165(1-2):1-2. PubMed ID: 25676698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biosimilars - Potential, risks and open questions].
    Dtsch Med Wochenschr; 2014 Jan; 139(1-2):12-3. PubMed ID: 24551883
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative cost savings of biosimilar and dose rounding utilization in oncology care.
    Abdelmeseh V; Brown BR; Huynh JP; Zullo AR
    J Oncol Pharm Pract; 2023 Sep; 29(6):1437-1442. PubMed ID: 36259235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How biosimilars will impact costs and care in oncology.
    Lyman GH
    Clin Adv Hematol Oncol; 2019 Oct; 17(10):544-547. PubMed ID: 31730579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.